Watching SCYNEXIS; Shares Trading Higher, Hearing GSK Is Close To Relaunching BREXAFEMME With The Co, FDA Updates BREXAFEMME Label With Pediatric Use Information And Revised Patient Safety Guidance

Benzinga Newsdesk www.benzinga.com Neutral 92.4%

Neg 0% Neu 92.4% Pos 0%

https://www.accessdata.fda.gov/scripts/cder/safetylabelingchanges/index.cfm?event=searchdetail.page&DrugNameID=2636#

Comments

No comments yet. Be the first!